Hangzhou Biotest Biotech Co.,Ltd.'s latest marketcap:
As of 08/29/2025, Hangzhou Biotest Biotech Co.,Ltd.'s market capitalization has reached $816.82 M. According to our data, Hangzhou Biotest Biotech Co.,Ltd. is the 11288th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 816.82 M |
| Revenue (ttm) | 71.76 M |
| Net Income (ttm) | 19.44 M |
| Shares Out | 146.32 M |
| EPS (ttm) | 0.13 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/06/2025 |
| Earnings Date | 08/29/2025 |
Hangzhou Biotest Biotech Co.,Ltd.'s yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/29/2025 | ¥5.82 B | $816.82 M | 74.25% | 11288 |
| 12/31/2024 | ¥3.45 B | $472.78 M | 6.92% | 13369 |
| 12/29/2023 | ¥3.23 B | $454.74 M | -34.48% | 13654 |
| 12/30/2022 | ¥4.93 B | $714.07 M | -33.91% | 10122 |
| 12/31/2021 | ¥7.46 B | $1.17 B | 8504 |
Company Profile
About Hangzhou Biotest Biotech Co.,Ltd.
Hangzhou Biotest Biotech Co.,Ltd. is a leading company specializing in the research, development, manufacturing, and distribution of in vitro diagnostic (IVD) assays, reagents, and instruments. Established in 2008 and headquartered in Hangzhou, China, the company serves both domestic and international markets.
Key Offerings
- Medical Test Products – Covering fertility health, cardiology, oncology, inflammation, biochemistry, and infectious diseases.
- Veterinary Test Kits – Designed for animal health diagnostics.
- Fluorescence Immunoassay Rapid Test Kits – Providing quick and accurate diagnostic solutions.
- Other Rapid Testing Kits – Catering to diverse diagnostic needs.
With a strong commitment to innovation and quality, Hangzhou Biotest Biotech continues to expand its portfolio to meet the evolving demands of the healthcare and veterinary industries.
Frequently Asked Questions
-
What is Hangzhou Biotest Biotech Co.,Ltd.'s (SHA-688767) current market cap?As of 08/29/2025, Hangzhou Biotest Biotech Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $816.82 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hangzhou Biotest Biotech Co.,Ltd. (SHA-688767) rank globally by market cap?Hangzhou Biotest Biotech Co.,Ltd. global market capitalization ranking is approximately 11288 as of 08/29/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.